» Articles » PMID: 32184633

Epidemiology and Mortality-Associated Factors of Invasive Fungal Disease in Elderly Patients: A 20-Year Retrospective Study from Southern China

Overview
Publisher Dove Medical Press
Date 2020 Mar 19
PMID 32184633
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Invasive fungal disease (IFD) is a life-threatening infection. The epidemiology and clinical features of IFD in the elderly population are less discussed. The aim of this study was to explore the epidemiology and mortality-associated factors for IFD in the elderly inpatients.

Methods: A retrospective study enrolling 512 elderly inpatients from The First Affiliated Hospital of Sun Yat-sen University during the last two decades was performed.

Results: The annual prevalence of IFD was 0.1-0.5%. Candidiasis was the most common (236/521, 45.3%). An increasing trend was observed in aspergillosis from 11.1% in year 1998 to 28.8% in year 2018. The common infective sites of candidiasis were abdominal cavity (83/236, 35.2%) and bloodstream (55/236, 23.3%). Invasive aspergillosis mainly developed in the sinus (74/149, 49.7%) and lung (65/149, 43.6%). Patients with diabetes mellitus (DM) (59/126, 46.8%), solid organ malignancy (84/114, 73.7%), chronic kidney disease (CKD) (40/62, 64.5%) or receiving operation (109/147, 74.1%) were prone to develop candidiasis, while aspergillosis was usually complicated in patients with chronic obstructive pulmonary disease (COPD) (25/51, 49.0%). The all-cause mortality rate was 25.9% (135/521), and patients aged ≥80 years were the riskiest (20/51, 39.2%). Lymphopenia (59.5% vs 17.3%, <0.001) was significant in deceased patients with mold infection. Higher proportion of non-survivors with invasive candidiasis received central venous catheterization (CVC) (68.4% vs 40.6%, <0.001) or indwelling urinary catheter (68.4% vs 46.3%, =0.001).

Conclusion: IFD is a life-threatening complication especially in the oldest-old. Surveillance on lymphopenia, prompt treatment and reduce invasive procedures could benefit the prognosis.

Citing Articles

with Mycovirus as an Etiologic Factor for Acute Leukemias in Susceptible Individuals: Evidence and Discussion.

Tebbi C, Sahakian E, Shah B, Yan J, Mediavilla-Varela M, Patel S Biomedicines. 2025; 13(2).

PMID: 40002901 PMC: 11853382. DOI: 10.3390/biomedicines13020488.


Predicting intra-abdominal candidiasis in elderly septic patients using machine learning based on lymphocyte subtyping: a prospective cohort study.

Zhang J, Zhao G, Lei X, Cui N Front Pharmacol. 2024; 15:1486346.

PMID: 39726780 PMC: 11669700. DOI: 10.3389/fphar.2024.1486346.


Patterns of Amphotericin B Use and Factors Related to Mortality in a Low-Middle Income Country: An Observational and Longitudinal Study.

Valladales-Restrepo L, Soto-Romero L, Navarrete-Santa L, Montoya-Garcia R, Rios-Montoya J, Sabogal-Ortiz A Antibiotics (Basel). 2024; 13(11).

PMID: 39596710 PMC: 11591292. DOI: 10.3390/antibiotics13111015.


Causal relationship between type 1 diabetes mellitus and mycoses: a Mendelian randomization study.

Chen X, Chen C, Wu M, Wang S, Jiang H, Li Z Front Med (Lausanne). 2024; 11:1408297.

PMID: 38947239 PMC: 11211379. DOI: 10.3389/fmed.2024.1408297.


Clinico-Demographic Parameters of Oral Fungal Infections: An Institutional Retrospective Study.

Devi K, R A, Kizhakkoottu S Cureus. 2024; 16(3):e55386.

PMID: 38562320 PMC: 10983061. DOI: 10.7759/cureus.55386.


References
1.
Scott L . Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections. Drugs. 2012; 72(16):2141-65. DOI: 10.2165/11209970-000000000-00000. View

2.
Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M . A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015; 41(9):1601-10. DOI: 10.1007/s00134-015-3866-2. View

3.
Gosiewski T, Salamon D, Szopa M, Sroka A, Malecki M, Bulanda M . Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - a pilot study. Gut Pathog. 2014; 6(1):43. PMC: 4201707. DOI: 10.1186/s13099-014-0043-z. View

4.
Ramos-Martinez A, Vicente-Lopez N, Sanchez-Romero I, Padilla B, Merino-Amador P, Garnacho-Montero J . Epidemiology and prognosis of candidaemia in elderly patients. Mycoses. 2017; 60(12):808-817. DOI: 10.1111/myc.12677. View

5.
Pfaller M, Diekema D . Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20(1):133-63. PMC: 1797637. DOI: 10.1128/CMR.00029-06. View